Change in Health Related Quality of Life Scores as Measures by Functional Assessment of Cancer Therapy Bone Marrow Transplant (FACT-BMT)

Health Related Quality of Life will be measured using the Functional Assessment of Cancer Therapy Bone Marrow Transplant (FACT-BMT), a validated 47-item patient-reported outcome measure. It includes the FACT-G core questionnaire (Physical, Social/Family, Emotional, and Functional Well-Being) plus a Bone Marrow Transplant Subscale. Each item is rated on a 5-point Likert scale (0 = not at all; 4 = very much). Subscale scores are summed up to produce a total score, with higher scores indicating better quality of life. Change from baseline will be analyzed using mixed-effects models adjusted for baseline score. FACT-BMT total score (range: 0 to 176)

Baseline (T1), up to 18 months

Change in Pain as Measured by patient reported outcome measures (PROMIS®) pain scale.

(PROMIS®) pain scale is scored on a range of 3 to 15 with higher scores indicating higher pain.

Baseline (T1), up to 18 months

Change in Fatigue as Measured by patient reported outcome measures (PROMIS®) Fatigue scale.

(PROMIS®) Fatigue scale is scored on a range of 8 to 40. Higher scores indicate higher fatigue.

Baseline (T1), up to 18 months

Change in Cognitive Function Scores as Measured by The Fast Cognitive Evaluation (FaCE).

The Fast Cognitive Evaluation (FaCE) scores range from 0 to 27 with higher scores indicating better cognitive functioning.

Baseline (T1), up to 18 months

Change in Sleep Quality Scores as Measured by Pittsburgh Sleep Quality Index

Pittsburgh Sleep Quality Index score range from 0 to 21. Higher score indicate worse sleep quality.

Baseline (T1), up to 18 months

Number of Days to Engraftment Measured from Infusion to Engraftment.

To measure the number of days to engraftment we will extract from the electronic medical record (EMR) days from infusion to engraftment.

Up to 18 months

Number of Days of Hospitalization Measured from Admission to Engraftment.

To measure the number of days of hospitalization we will extract from the electronic medical record (EMR) days of hospitalization from admission to engraftment.

Up to 18 months

Number of Hospital Readmissions after Hospital Discharge

To measure the number of hospital readmissions we will extract from the electronic medical record (EMR) the number of hospital readmissions from hospital discharge.

Up to 100 days

Number of Infections from Hospital Admission

To measure the number of infections we will extract from the electronic medical record (EMR) the number of infections from hospital admission measure up to 100 days post infusion.

up to 100 Days Post-Infusion Day

Changes in Depression Scores as measured with the patient health questionnaire (PHQ-9)

PHQ-9 (patient health questionnaire) scores range is from 0 to 27; higher scores are associated with more severe depression.

Baseline (T1), up to 18 months

Changes in Anxiety Scores as measured with the Generalized Anxiety Disorder scale-7 (GAD-7).

GAD-7 scores range from 0 to 21; higher scores are associated with more severe anxiety.

Baseline (T1), up to 18 months

Change in Cancer-specific Distress Scores as Measured by the Impact of Events Scale-Revised

Impact of Events Scale-Revised range is 0 to 88; higher score is associated with more effect caused by events.

Baseline (T1), up to 18 months

Change in Serum Cortisol as Measured by ELISA

Serum cortisol levels are measured via ELISA. Serum Cortisol normal levels morning range: 10-20 mcg/dL ; afternoon range: 3-10 mcg/dL. Any values outside of the range are associated with higher stress and inflammation

Baseline (T1), up to 18 months

Change in Pro- and Anti-Inflammatory Cytokine Concentrations as Measured by Multiplex Immunoassay

Cytokines levels are measured in pg/mL. Plasma concentrations of 10 cytokines (GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, TNF-α) are measured via the Novex Life Technologies Human Cytokine 10-Plex Kit on the Magpix Luminex platform (ThermoFisher). Assay sensitivity is 0.5-5 pg/mL per analyte with a \>3-log dynamic range. Elevated pro-inflammatory cytokines (e.g., IL-1β, IL-6, TNF-α) and suppressed anti-inflammatory cytokines (e.g., IL-10) are associated with immune dysregulation and chronic stress.

Baseline (T1), up to 18 months

Change in Immunocompetence as Measured by Thymic Function

Thymic function T-cell receptor excision circles (TRECs) measured by TRECs/microliter.

Baseline (T1), up to 18 months

Change in Immunocompetence as Measured by Regulatory T cells

Regulatory T cells measured as cells/mm\^3

Baseline (T1), up to 18 months